Male Infertility Industry Data Book - Male Infertility Diagnosis and Male Infertility Treatment Market Size, Share, Trends Report

Male Infertility Industry Data Book - Male Infertility Diagnosis and Male Infertility Treatment Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030

  • Published Date: Jul, 2023
  • Report ID: sector-report-00178
  • Format: Electronic (PDF)
  • Number of Pages: 350

Database Overview

Grand View Research’s male infertility industry data book is a collection of market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses, and regulatory & technological framework studies. Within the purview of the database, such information is systematically analyzed and provided in the form of outlook reports and summary presentations on individual areas of research along with a digital healthcare statistics e-book.

Male Infertility Industry Data Book Scope



Areas of Research

  • Male Infertility Diagnosis Market
  • Male Infertility Treatment Market

Number of Reports/Presentations in the bundle

  • 2 Individual Reports - PDFs
  • 2 Individual Reports - Excel
  • 1 Data book - Excel

Country Coverage

25+ Countries

Cumulative Coverage of Products

30+ Companies and respective product benchmarking

Highlights of Datasets

  • End-use Revenue, by Countries
  • Competitive Landscape
  • Regulatory and Reimbursement Guidelines, by Countries

Total Number of Tables (Excel) in the Bundle


Total Number of Figures in the Bundle


Male Infertility Industry Data Book Coverage Snapshot

Markets Covered

Male Infertility Industry

USD 4.03 billion in 2022

4.95% CAGR (2023-2030)

Male Infertility Diagnosis Market Size

USD 343.8 million in 2022

5.89% CAGR (2023-2030)

Male Infertility Treatment Market Size

USD 3.68 billion in 2022

4.86% CAGR (2023-2030)


Male Infertility Sector Outlook

The global male infertility market size was valued at USD 4.03 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 4.95% from 2023 to 2030.

New product approvals, commercialization of home-based diagnostic kits, increase in the incidence of infertility leading to higher diagnosis rate, and rise in awareness are some of the key factors expected to drive the market.

Increasing demand for Assisted Reproductive Technology (ART) is a major cause of the growth in the male infertility industry’s global revenue. ARTs can help males with no sperm, abnormal sperm, or sperm with poor motility. Furthermore, a higher success rate than other medications and advancements in technology are expected to increase the demand for ART, which is likely to drive the market over the forecast period. 

Male Infertility - Market Facts

 Regional Male Infertility Market Size, (USD Million)

Regional Market Penetration, 2022 Size, (USD Billion)

Key Regional Trends

Europe dominated the market in 2022 owing to increased adoption and diagnosis rate dye to technological developments and high affordability.

Male Infertility Diagnosis Market Analysis And Forecast

The global male infertility diagnosis market size was valued at USD 343.8 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.89% from 2023 to 2030. A study published in the Journal of Urology in 2020 mentioned that the prevalence of male infertility in the U.S. was around 15%. This can be attributed to the increase in consumption of alcohol, smoking, obesity, stress, and lifestyle changes. Studies have shown that smoking can damage sperm DNA, reduce sperm motility & count, and increase the percentage of abnormal sperm. It can also lead to erectile dysfunction and decreased libido. Smoking can also affect the success rate of ARTs, such as IVF. Thus, as a result of the abovementioned factors, the increasing incidence of infertility is expected to help the market grow. Microscopic examination is an important diagnostic test for male infertility. It involves the analysis of a semen sample under a microscope to evaluate the quantity, quality, and motility of sperm. The test can help identify issues such as low sperm count, poor sperm motility, and abnormal sperm morphology. 

Global Male Infertility Diagnosis Market Share, by Techniques, 2022 (%)

Based on diagnosis techniques, DNA fragmentation test accounted for the largest share of 21.76% of the diagnosis market in 2022, due to its ability to provide reliable analysis of sperm DNA integrity. It is also expected to exhibit the strongest growth during the forecast period. The manual method is still widely used for semen analysis in developing economies. However, this method is expected to be replaced by computer-assisted semen analysis in the coming years.

Male Infertility Treatment Market Analysis And Forecast

The global male infertility treatment market is valued at USD 3.68 billion as of 2022 and is expected to expand at a CAGR of 4.86% for the forecast period 2023-2030. High adoption of Assisted Reproductive Technology (ART) is a significant driver for the male infertility market. The increasing awareness and acceptance of ART have led to a surge in demand for these procedures. According to a report by the Centers for Disease Control and Prevention (CDC), the use of ART has doubled in the past decade in the U.S. alone.

U.S. Male Infertility Treatment Market Size, 2020 - 2030 (USD Million)

In 2022, ART dominated the market with a revenue share of 71.11% and is likely to maintain its lead during the forecast period. Drugs and hormonal therapy are preferred for initial treatment. ART is usually preferred in case treatment with medication fails.

Furthermore, advancements in technology and techniques have significantly improved the success rate of ART procedures. For instance, the use of Preimplantation Genetic Testing (PGT) has resulted in higher success rates of IVF procedures by helping identify chromosomally normal embryos. Hence, as a result of the aforementioned factors, the male infertility market may grow over the forecast period.

Competitive Insights

Development of innovative technologies, acquisitions, and partnerships or collaborations for the development & commercialization of products are some of the key strategies undertaken by companies to remain competitive in the market. For instance, in October 2022, Endo International plc and the Sexual Medicine Society of North America (SMSNA) reported the launch of Peyronie's Self-Assessment app. Moreover, market players are availing certification from regulatory agencies to strengthen their position in the market. 

Key Drivers

  • Increasing incidence rate of infertility

  • High adoption of Assisted Reproductive Technology (ART)

  • Technological advancements

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member


ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.